Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide typically begins to affect appetite within the first one to two weeks of treatment, though meaningful weight change takes longer — most people notice a clear shift by weeks four to eight, once the dose has had time to settle. That said, the timeline varies person to person, and how quickly it kicks in depends on several things worth understanding before you judge whether it's working. These are prescription-only medicines requiring clinical assessment; a prescriber decides whether treatment is suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That question tends to arrive around week three or four, when the novelty has worn off and the scale hasn't moved as dramatically as expected. It's a completely understandable place to be. The honest answer is that you're almost certainly still in the adjustment phase, and judging tirzepatide at this point is a bit like leaving a film after the opening credits.
Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) which together reduce appetite, slow how quickly the stomach empties and improve how the body handles blood sugar. Those mechanisms take time to translate into fat loss. Blood levels of the medicine build up over several weeks of weekly injections, and the titration schedule (which typically moves up every four weeks, starting at 2.5mg) means you won't reach a therapeutically meaningful dose for at least a month. The 2.5mg starting pen's job is to help your system adjust, not to produce the results you signed up for. Real momentum tends to come once you're at 5mg or above.
For more on the overall arc of how tirzepatide delivers results, our detailed timeline guide walks through each phase of treatment week by week.
In SURMOUNT-1, the landmark 72-week study of tirzepatide in adults with obesity, participants lost an average of around 20–21% of body weight at the 15mg dose. That figure comes from the full SURMOUNT-1 paper published in the New England Journal of Medicine, which enrolled 2,539 adults, not tens of thousands, as sometimes gets quoted. Weight loss wasn't front-loaded. Participants continued losing weight across the entire 72 weeks, meaning the medicine was still working at week 60 in ways it wasn't at week 10.
The practical implication: a slow start is the norm, not a signal that your prescription is wrong. People who lost the most weight by the end of the trial weren't necessarily the fastest starters. Consistency and dose escalation (guided by your prescriber) drove the outcomes.
NICE, in its appraisal of tirzepatide (TA1026), uses the same trial evidence to underpin its recommendations and sets a clear review point: if fewer than 5% of body weight has been lost after six months at the highest tolerated dose, continuing should be reassessed. That gives you a real, evidence-based benchmark rather than a feeling. You can read NICE's full guidance on tirzepatide directly.
Starting dose and titration pace matter more than most people expect. If you want a closer look at how long before tirzepatide kicks in at each stage of the titration schedule, the answer depends partly on how smoothly your body tolerates each dose step. Someone who needs to slow their titration due to nausea will naturally reach their optimal dose later than someone who tolerates each step easily.
Lifestyle factors alongside treatment are also relevant. Tirzepatide is licensed as an adjunct to a reduced-calorie diet and increased physical activity. The trial participants followed structured behavioural support programmes. That doesn't mean you need a formal programme, but it does mean the medicine works in context, not in isolation. Prioritising protein intake and keeping up some form of activity can help preserve muscle as weight comes off, your prescriber or a dietitian can advise on the specifics for you.
Individual biology plays a role too. Metabolic rate, gut transit time, how someone responds to appetite signalling, all of these differ. Readers who are curious about how long till tirzepatide kicks in for different people will find that some report a noticeable change in hunger by day five, while others don't feel the shift until they're three or four weeks in. Neither is wrong.
If you're weighing up how Mounjaro (the brand name for tirzepatide in the UK) compares to other treatment options, our weight-loss treatments overview sets out what's currently available and licensed.
Slow initial results are expected and normal. But some situations do warrant a conversation before your next scheduled review. If you're experiencing persistent nausea that isn't easing after two weeks at a given dose, your prescriber may suggest holding the dose rather than escalating. A common question at this stage is how long does it take for Mounjaro to kick in, and if you're several months into treatment at a stable dose and weight hasn't shifted at all, that's worth flagging rather than waiting for the six-month mark.
Serious side effects (severe, persistent stomach pain that radiates to the back, signs of an allergic reaction, or symptoms of dehydration from prolonged vomiting) need prompt medical attention rather than a message to your clinic. The NHS medicines page for tirzepatide lists symptoms that require urgent care and is worth bookmarking when you start treatment.
For context on how long Mounjaro takes to work compared with semaglutide (Wegovy), this related page on Mounjaro's onset covers the comparison in detail. And if you have questions about how the prescription process works through a GPhC-registered online pharmacy, our FAQs are a good starting point before you speak to our clinical team.
If you're ready to find out whether tirzepatide is clinically suitable for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.